The first FDA-approved treatment for equine protozoal myeloencephalitis (EPM).
- Ponazuril, the active ingredient, crosses the blood/brain barrier to reach the central nervous system where it kills Sarcocystis neurona
- Precalibrated oral dosing syringe ensures accurate delivery of each dose
- Easy to administer correctly; the horse owner can give the full dose each time